Apr
28
2022
On demand

Strategic supply chain design: flexibility and scalability considerations for optimal facility design

Live30 webinars are thirty minute presentations designed to update you on the latest innovations, applications and data in a fast yet interactive format.

The development of individualized medicine, as part of Cell & Gene Therapy (C&GT) platforms, is one of the greatest promises of the biopharmaceutical industry. The pipeline of advanced therapies is expanding, with several cell and gene therapies now reaching the market. The services required to develop them are in more demand than ever.

With new developments in the market, and high demand comes complex challenges with scalability. This presentation will explore C&GT supply chains challenges and drill down to its impact on facility operations and sizing concerns. We will focus on autologous therapies while discussing commonalities and differences with allogeneic therapies'.

  • How to approach facility readiness to unforeseen and often long lasting supply chain issues
  • How to appropriately size the spaces and systems around uncertainty
  • How to include flexibility and phasing considerations in facility design

Niranjan Kulkarni, PhD

Senior Director, Consulting Services, CRB

Niranjan is the senior director of consulting services at CRB. He holds a doctorate and master’s degree in industrial and systems engineering from Binghamton University. He is also a certified Lean Six Sigma Master Black Belt. Niranjan has over 15 years of experience in business process and data modeling, operations and process simulations, process improvements, layout optimizations and supply chain management. He has worked with the pharmaceutical, biotech, food, chemical, semiconductor, electronics assembly and packaging, manufacturing and financial industries

Grace Linton, RA, AIA, LEED AP BD+C

Director of Process Architecture, CRB

Grace is the director of process architecture at CRB. She supports the advancement of CRB's process architectural preeminence, with a focus on cGMP regulatory expertise, integrated facility design, and innovative design solutions. Grace has delivered projects in North America, Europe and Asia, covering a wide range of facility types, including cell and gene therapy, monoclonal antibodies, vaccines, blood fractionation, active pharmaceutical ingredients, oral solid dosage, medical devices, fill finish, and oligonucleotides.

SPEAKERS

Niranjan Kulkarni, PhD
Senior Director, Consulting Services at CRB
Grace Linton, RA, AIA, LEED AP BD+C
Director of Process Architecture at CRB

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
36
Days
8
Hrs
31
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
14
Days
8
Hrs
31
Min
Register

Improving T cell therapy manufacturing processes with automation and...

E Zynda, PhD
Evan Zynda, PhD
Evan Zynda, PhD
Staff Scientist, Cell Biology at Thermo Fisher Scientific
26 May 2022
9
Days
8
Hrs
31
Min
Register

Streamlined workflow solutions for cell and gene therapy analytics

A Graband
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
24 May 2022
7
Days
8
Hrs
31
Min
Register

Strategic partnering to enable cell therapy commercialization

J Smith
X de Mollerat du Jeu
Jenessa Smith
Jenessa Smith
Associate Director of Process Development at ArsenalBio
Xavier de Mollerat du Jeu
Xavier de Mollerat du Jeu
Senior Director, R&D, Cell and Gene Therapy at Thermo Fisher Scientific
12 May 2022
Watch now